TickerKhojComparison · NSE · data 2026-11-02
Ambalal Sarabhai Enterprises Limited vs Jenburkt Pharmaceuticals Ltd
In plain words
Size: Jenburkt Pharmaceuticals Ltd is about 1.4 times the market value of Ambalal Sarabhai Enterprises Limited.
Valuation (P/E): Ambalal Sarabhai Enterprises Limited 19.6 vs Jenburkt Pharmaceuticals Ltd 11.6.
Return on equity: Jenburkt Pharmaceuticals Ltd 18.8% vs Ambalal Sarabhai Enterprises Limited 11.9%.
Profit growth over 3 years: Ambalal Sarabhai Enterprises Limited 15.9% a year vs Jenburkt Pharmaceuticals Ltd 12.2% a year.
Debt to equity: Ambalal Sarabhai Enterprises Limited 0.36 vs Jenburkt Pharmaceuticals Ltd 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AMBALALSA | JENBURPH | |
|---|---|---|
| Price | ₹34.75 | ₹863.1 |
| Market cap | ₹268 cr | ₹377 cr |
| P/E | 19.6 | 11.6 |
| P/B | — | — |
| ROE | 11.9% | 18.8% |
| ROCE | 9.4% | 22.7% |
| Debt / equity | 0.36 | 0.01 |
| Operating margin | 5.1% | 22.4% |
| Dividend yield | 0.00% | 2.42% |
| Sales growth, 3 years (yearly) | 5.9% | 7.3% |
| Profit growth, 3 years (yearly) | 15.9% | 12.2% |
| 1-year return | 7.6% | -17.2% |
| Revenue, last 12 months | ₹206 cr | ₹169 cr |
| Net profit, last 12 months | ₹14 cr | ₹33 cr |
| Latest quarter | — | — |
| Quarter net profit | — | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | — |
| Health check | Average (6.1/10) | Strong (6.8/10) |
Common questions
Which has a higher P/E, Ambalal Sarabhai Enterprises Limited or Jenburkt Pharmaceuticals Ltd?
Ambalal Sarabhai Enterprises Limited trades at the higher P/E (19.6 against 11.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Jenburkt Pharmaceuticals Ltd (18.8% against 11.9%).
Which carries more debt?
Ambalal Sarabhai Enterprises Limited has the higher debt-to-equity ratio (0.36 against 0.01).